Together with my business partners for specialized data analysis and my husband with his company CastellIT, who takes care of the data-storage, report automation and ICT infrastructure, we are able to offer you a variety of analyses.
The company started in April 2018 with preclinical analyses of nucleotide sugars for a start-up pharmaceutical company in San Francisco (US), to aim for the first medicine for the rare disorder PMM2-CDG, a congenital disorder of glycosylation.
GlycoMScan provides contract research and analytical services for pharma, life sciences companies and academia. We are specialized in mass spectrometry and have a background in protein and glycosylation analyses, especially in the building blocks thereof which are present in the intracellular metabolism.
More about GlycoMScan
Welcome at GlycoMScan B.V.
Are you looking for high quality services, with short communication lines and time-to-results? We are happy to offer you analytical services, research and consultancy in mass spectrometry for pharma and life sciences.
With a unique background as PhD in Pharmacy and Chemistry, we have a broad knowledge in the analysis of molecules, ranging from small organic molecules to large proteins such as therapeutic antibodies.
Our expertise is the analysis of protein glycosylation and the building blocks thereof, which are nucleotide sugars. For more information, please follow the links "Expertise", “Services” or feel free to contact us by email: email@example.com